Studies have suggested that Oct4 and Nanog may participate in the tumorigenicity and tumor progression of various types of cancer, including breast cancer, glioma, human endometrial adenocarcinoma, gastric cancer and colorectal cancer (29–33). The gene discussed is POU5F1; the disease is breast cancer.